Q
Cancer researchers claim 'extraordinary results' using T-cell therapy
‘This is unprecedented’ says researcher after more than half of terminally ill blood cancer patients experienced complete remission in early clinical trials
Tuesday 16 February 2016
https://www.theguardian.com/science...sults-t-cell-therapy-research-clinical-trials
... ...
In the most promising study, about 35 patients with ALL were treated with Cars-modified T-cells; 94% went into remission, though symptoms could reappear. More than 40 patients with lymphoma have also been treated, with remission rates of more than 50%. In a group with non-Hodgkin’s lymphoma, there was evidence of diminished cancer symptoms in more than 80% of cases.
“Much like chemotherapy and radiotherapy, it’s not going to be a save-all,” Riddell said of the new therapy, adding: “I think immunotherapy has finally made it to a pillar of cancer therapy.”
A paper on the ALL research is currently under review and pending publication.
UQ
Cancer researchers claim 'extraordinary results' using T-cell therapy
‘This is unprecedented’ says researcher after more than half of terminally ill blood cancer patients experienced complete remission in early clinical trials
Tuesday 16 February 2016
https://www.theguardian.com/science...sults-t-cell-therapy-research-clinical-trials
... ...
In the most promising study, about 35 patients with ALL were treated with Cars-modified T-cells; 94% went into remission, though symptoms could reappear. More than 40 patients with lymphoma have also been treated, with remission rates of more than 50%. In a group with non-Hodgkin’s lymphoma, there was evidence of diminished cancer symptoms in more than 80% of cases.
“Much like chemotherapy and radiotherapy, it’s not going to be a save-all,” Riddell said of the new therapy, adding: “I think immunotherapy has finally made it to a pillar of cancer therapy.”
A paper on the ALL research is currently under review and pending publication.
UQ